Newsoara Biopharma
Privately held: no public share price · China
Assets
(3 total)
3Total Assets
1Approved
1Phase 3 / Filed
1Phase 1–2 / Early
3Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
Bexagliflozin(Brenzavvy) | Approved | SGLT2Small molecule | Type 2 Diabetes |
| Phase 3 | PDE4Small molecule | Psoriasis | |
| Phase 1 | Undisclosed / early pipelineSmall molecule | Non-Small Cell Lung Cancer |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Regulatory and conference events
(2)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent
Financial reports
No financial reports recorded.